Standard aplastic anemia therapy improves patient outcomes better than newer version
Links shared publicly online about this topic.
- 98total visits
Standard aplastic anemia therapy improves patient outcomes better than newer version
A comparison clinical study of two aplastic anemia treatments found that ATGAM, currently the only licensed aplastic anemia drug in the United States, improved blood cell counts and survival significantly more than did Thymoglobulin, a similar but reportedly more potent treatment. The research was funded ...
View full resource at medicalxpress.com
Tags: Anemia, Anemia Medication, Aplastic Anemia, Drug
Most Recently Shared on August 4, 2011 at 7:50 am By:
Standard aplastic anemia therapy improves patient outcomes better than newer version http://tw.medicalxpress.com/231646838
Standard aplastic anemia therapy improves patient outcomes better than newer version, study finds
sciencedaily.com — “A comparison clinical study of two aplastic anemia treatments found that ATGAM, currently the only licensed aplastic anemia drug in the United States, improved blood cell counts and survival significantly more than did Thymoglobulin, a similar but reportedly more potent treatment.” View full resource at sciencedaily.com
Most Recently Shared on August 3, 2011 at 11:48 pm By:
Standard aplastic anemia therapy improves patient outcomes better than newer version, study finds http://bit.ly/mZ0bYA
Advertisement
